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Summary
Healthcare systems are complex, multi-level, highly integrated 
organizations, comprising of different professional figures, insti-
tutions, and resources. Such breadth and complexity reflect the 
multi-dimensionality of the concept of health, which implies 
the adoption of a holistic approach. Health, rather than merely 
being the absence of disorders or infirmity, is a highly dynamic 
state, which represents the abilities of an individual to cope with 
adverse social, physical and emotional/psychological events and 
conditions, continuously adapting to them. Ensuring an adequate 
health state is one of the most important concerns, and the health-
care systems are called to renew themselves in order to meet with 
the new challenges and health needs. Throughout the last dec-
ades, due to demographic shifts and transitions, epidemiological 
and societal changes, technological achievements and scientific 
advancements, healthcare systems have undergone an extensive 
series of reform plans. Therefore, health policy- and decision-
makers have made efforts to develop and implement initiatives 
for preserving the quality of the healthcare provisions. Strategic 
purchasing is an approach of purchasing that takes into account 
several health-related issues such as a proper, comprehensive 
planning of service delivery, the design and selection of the best 
packages of services and provisions, the appropriate selection of 
providers and the allocation of economical and financial incen-
tives to provide better services and to motivate managers to adopt 
appropriate policies to implement strategic purchasing. Here, we 
intend to consider the various dimensions and aspects that can be 
effective in strategic purchasing, as well as the main barriers and 
obstacles that hinder its full implementation.
No healthcare system is an island: 
complexity of the health organizations
Healthcare systems are complex, multi-level, highly in-
tegrated and coordinated organizations, comprising of 
different professional figures, institutions, settings and 
resources [1]. As such, they represent the key determi-
nants of well-being in the modern-day society, being a 
valuable asset that deliver high-quality health provisions, 
trying to address the health needs of the target popula-
tion and to ensure optimal quality of life, functioning, 
productivity and prosperity [2]. Healthcare systems are 
an array of cultural and organizational competencies 
and skills, staff and workforce, economic and financial 
resources, infrastructures, information technologies, so-
phisticated equipment and facilities  [3]. Such breadth 
and complexity reflect the multi-dimensionality of the 
concept of health, which implies the adoption of a holis-
tic approach [4]. 
Health, rather than merely being the absence of disorders 
or infirmity, is a highly dynamic state, which represents 
the abilities of an individual to cope with adverse social, 
physical and emotional/psychological events and condi-
tions, and to overcome them, continuously adapting to 
them [5]. Ensuring an adequate health state is one of the 
most important concerns as of today, and the healthcare 
systems are called to renew themselves in order to meet 
with the new challenges and health needs, reflecting the 
persistent importance and growing role of policy- and 
decision-making, state governance and inter-depart-
mental leadership, aiming at maintaining and improving 
people’s health in its various dimensions [6].
Healthcare systems are not islands, that is to say iso-
lated organisms, but interact with a variety of bodies, 
including other health  –  and more specifically, public 
health – agencies, regulators, purchasers and clients at 
an inter-sectoral level [7].
Throughout the last decades, due to unprecedented de-
mographic shifts and transitions, epidemiological and 
societal changes, including aging population, increased 
life expectancy, long-term decline in birth rate and the 
shift from acute communicable disorders to chronic-de-
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generative non-communicable diseases, as well as due 
to technological achievements and scientific advance-
ments, healthcare systems have undergone an extensive 
series of reform plans [8, 9].
These aspects are, undoubtedly, among the most impor-
tant factors directly affecting the delivery of healthcare 
services and, as such, impacting on the well-being of the 
society. Therefore, health policy- and decision-makers 
have made efforts to develop and implement initia-
tives for preserving the quality of the healthcare provi-
sions [10]. These reforms have aimed at increasing the 
sustainability of the health organizations, managing the 
rising costs of development and service delivery, prob-
ing and ensuring the tenability of health systems in a 
globalizing world and promoting the increasing impor-
tance of health problems related to lifestyle, environ-
mental and living conditions [11, 12].
Yet, despite such impressive efforts, these reforms and 
initiatives have failed to provide a true solution to the 
growing economical, financial and organizational/logis-
tical problems that nowadays healthcare systems have to 
face [13].
In the next paragraph, we will briefly overview the mean-
ing and the role of strategic purchasing in healthcare or-
ganizations. For the present article, we have conducted 
a literature review using “strategic purchasing” as major 
key-word and mining the entire content of the PubMed/
MEDLINE scholarly database, since its inception, with 
no time or language filters. Furthermore, we have relied 
on the expertise of our group, which has already pub-
lished on this topic. 
The role of strategic purchasing
The rising costs of services provided in the health sec-
tor represent a significant challenge. Problems such as 
resources waste, leakages and low efficiency [14], lack 
of social justice and fairness in access to healthcare ser-
vices and inappropriate use of financial resources are the 
main weaknesses that plague the traditional way of pur-
chasing health services and provisions [15]. 
Strategic purchasing is a concept initially introduced 
by the Thatcher’s government (Tab. I), implying an 
active role of purchasers in contracting and buying, 
in which aspects like population needs and health, 
quality, scientific evidence, efficiency and effective-
ness, and equity and fairness are incorporated  [16]. 
As such, strategic purchasing is a highly participatory 
and shared series of processes, in which a variety of 
stakeholders (from citizens and patients to purchas-
ers, providers, regulators, and governments) [15] are 
actively involved. This calls up for a shift from pas-
sive to active purchasing [17].
In 2000, the World Health Organization (WHO), in its 
report, recommended the adoption of strategic purchas-
ing as a valuable tool for improving the healthcare sys-
tem’s performance and the quality of service delivery, 
increasing responsiveness, ensuring fairness in funding 
allocation and a wider access to healthcare services [18].
Strategic purchasing as a dynamic and non-traditional 
process of contracting and purchasing has led to the fol-
lowing questions: namely, i) which healthcare services 
we should buy, ii) from whom we should buy healthcare 
services, iii) how healthcare services should be bought, 
and iv)  how much money we should pay for buying 
healthcare services [18, 19].
Strategic purchasing as an important strategy requires 
attention to several health-related issues such as a proper 
and comprehensive planning of service delivery in the 
different health sectors, the design and selection of the 
best packages of services and provisions, the appropriate 
selection of providers and the allocation of economical 
and financial incentives to provide better services and to 
motivate managers to adopt appropriate policies to im-
plement strategic purchasing [4, 20].
Indeed, the different aspects and dimensions of strate-
gic purchasing should be taken into account when im-
plementing a policy  [16]. Undoubtedly, if policy- and 
decision-makers in the world are trying to achieve the 
ambitious goal of the universal healthcare or Universal 
Health Coverage (UHC) [21], they should pay particular 
attention to strategic purchasing and they should identify 
and address the opportunities as well as the challenges 
they are facing. UHC requires the development of new 
financing schemes and, as such, strategic purchasing can 
be a very valuable tool to reach that goal  [20]. Health 
policy- and decision-makers should consider the four di-
mensions of strategic purchasing, in terms of the above-
mentioned questions, in order to develop an appropriate 
strategy (Fig. 1). 
In the current paper, we intend to consider the various 
dimensions and aspects that can be effective to ensure 
strategic purchasing, as well as the main barriers and ob-
stacles that hinder its full implementation.
Which healthcare services should we buy?
Health systems offer a high variety of services; as such, 
health policy- and decision-makers are trying to pro-
vide service recipients with a suitable and comprehen-
Tab. I. An overview of the major steps in the development of strategic purchasing as a main concept for healthcare organizations and systems.
Year Major event
1979-1990 Introduction of the concept of strategic purchasing during the Thatcher’s government
2000 The WHO recommended the adoption of strategic purchasing from healthcare systems and organizations
2005 A similar recommendation is made by the RESYST consortium
2007
A similar recommendation is made by the European Observatory, the World Bank and the Department of Health 
of several countries, including the UK
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sive package of services [22]. The precise nature of this 
package is one of the challenges that health managers 
have to face: the package of services can vary according 
to the specific needs and available resources and facili-
ties of each country or setting in which they are offered, 
but an array of minimum essential services should be 
guaranteed at least. In identifying health needs, health 
policy- and decision-makers should combine the meth-
odological rigor and transparency of the epidemiological 
surveys and investigations with fairness and equity in ac-
cess to healthcare services [20]. 
Ethical aspects should be always considered when plan-
ning and implementing programs in the health sector, 
taking into account also patients’ values, preferences 
and perspectives [2, 19].
An approach that integrates both components is, for in-
stance, the Health Technology Assessment (HTA), which, 
being based on a multi-disciplinary, multi-dimensional 
framework, can play a major role in determining the type 
and number of services to offer and in providing policy- 
and decision-makers with valuable evidence, while ensur-
ing economic and financial sustainability [19].
From whom should we buy healthcare 
services?
The relationship between purchaser and provider is of 
crucial importance in funding allocation in the health 
sector [23]. Service providers (either private or public) 
can have a direct impact on strategic purchasing-based 
strategies and policies. The number, the nature of pro-
viders and the conditions they impose are all factors that 
influence funding allocation  [24]. Purchasers should 
identify and choose the best healthcare providers, but, 
often, information on costs is not transparent or reliable, 
hindering purchasers from having a full control over the 
procedure of providers selection  [3]. This represents, 
indeed, a true and fundamental challenge. Failure to 
provide and disclose proper and relevant information re-
garding service costs to providers will result in a lack of 
strategic purchasing [4].
The criteria for selecting providers should be clearly a 
priori defined: high quality and high standards should be 
met, without the interference of political lobbies. Sepa-
ration/split between the purchasers and the service pro-
Fig. 1. The key components of strategic purchasing. 
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viders is an adequate model for achieving a transparent 
contracting and strategic purchasing [25]. 
How should healthcare services be 
bought?
This is another important challenge for health deci-
sion- and policy-makers. The solution can also vary, 
depending on the type of insurance system adopted in 
each country  [12]. The involvement of insurers makes 
it possible for health managers to develop and imple-
ment high-quality packages of healthcare services and 
provisions. Negotiations can, indeed, have a major role 
in contracting and strategic purchasing [26].
Government institutions, the intrinsic duty of which is to 
monitor and guarantee high quality, should be involved 
in all the steps and stages of the process of strategic 
purchasing  [7]. The use of electronic records, quality 
indicators and appropriate feedback systems can be ex-
tremely helpful in monitoring and keeping track of the 
buying process [27].
How much money should we pay for 
buying healthcare services?
Economical and financial resources for properly imple-
menting and making effective contracting and strategic 
purchasing are another big issue that should be taken into 
serious consideration [28]. Since the amount of money 
available is limited, the principle of cost-effectiveness 
should be adopted in order to prioritize the healthcare 
services offered in the package of provisions [21]. 
Barriers and obstacles to the full 
implementation of strategic purchasing
The shift from passive (or traditional) purchasing to 
strategic active purchasing is not without any barrier or 
obstacle [15]. First, health policy- and decision-makers 
need a specific framework that can be implemented: as 
such, the existence of a precise definition of what con-
tracting and strategic purchasing-based processes are is 
of crucial importance [3, 15].
Recently, Klasa and colleagues  [15], synthesizing and 
harmonizing the various definitions of strategic purchas-
ing from the WHO, the Word Bank, the RESYST consor-
tium, the European Observatory and the UK Department 
of Health, have proposed to define strategic purchasing 
as “an evidence-based process that sculpts health care 
systems by prioritizing the financing of certain goods 
and services over others through collaborative planning 
across various healthcare stakeholders while incorporat-
ing the needs and priorities of citizens in the distribution 
of health care and promoting equity, quality of care, ef-
ficiency, and responsiveness in the provision of health 
services” [4, 15].
This conceptual framework can be the basis for reaching 
a consensus among scholars and different health-related 
organisms, paving the way for conducting ad hoc studies 
and establishing adequate measures and interventions 
for reaching the ambitious goal [4, 8, 15]. 
Other factors that prevent the full implementation of 
strategic purchasing can be collected from the existing 
scholarly literature. For instance, our group has recently 
performed a qualitative study and framework analysis in 
Iran in 2014-15, sampling 34 individuals from decision- 
and policy-makers and executives of the “Iran Health 
Insurance Organization” (IHIO), stakeholders involved 
in the purchasing process, and university experts  [3]. 
We were able to identify 12 main themes: namely, i) the 
regulatory aspect (laws and regulations for purchasing), 
ii) the organizational aspects of the purchasing process 
and how strategic purchasing is structured and imple-
mented, iii) the choice of qualified and authorized pro-
viders (healthcare services providers selection), iv)  the 
identification of the right type of health services and 
provisions, v)  the design and development of the right 
type of contracts, vi)  the identification of the target 
group(s) for purchasing, vii) the financial and economi-
cal schemes and constraints (in terms of funding and 
resources allocation, financing and pricing systems), 
viii)  strategic purchasing as a way for improving per-
formance and increasing the quality of health services 
offered, ix) strategic purchasing as a strategy for shap-
ing the market and increasing competition, x) strategic 
purchasing as a tool for ensuring good health state for 
people and society, xi) guided strategic purchasing and 
governmental stewardship, and xii) the political and or-
ganizational issues (in terms of structure of the decision-
making process implemented in the health and welfare 
ministries). 
Always in Iran, Kalantari et al. [25] have recently con-
ducted a similar study, finding 5 main concepts: namely, 
i) political economy, ii) policy design, iii) organization-
al/logistic structure, iv) organizational environment, and 
v) management capacity. A study by Ghoddoosi-Nejad 
and coworkers [23] has identified stewardship as a major 
challenge in fully implementing the strategic purchasing 
process of healthcare services and provisions. More in 
detail, this challenge has been classified into three main 
themes and nine subthemes, with a lack of adequate 
management information systems, enforcement for rules 
and laws, stewardship units, and the conflict of interest 
between the Ministry of Health and insurers as purchas-
ers being the major obstacles.
Similar findings have been found in other countries. For 
instance, in Mexico [24], the major barriers to strategic 
purchasing are represented by the lack of specific funds 
allocated by the system of social protection in health and 
the autonomy of healthcare service providers, in order to 
reduce out-of-pocket (OOP) expenditure and to ensure 
equity in access to high-quality services.
Similar problems have been described in Cambodia [20] 
where the establishment of ad hoc funds (the health eq-
uity funds, or HEQs) has curbed the phenomenon of 
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OOP expenses from patients and facilitated the achieve-
ment the goal of strategic purchasing.
On the other hand, also in developed countries, strate-
gic purchasing is yet to be fully implemented [15]. As 
maintained by Klasa and collaborators [15] as of today, 
there is little evidence of the positive impact and benefits 
of strategic purchasing in terms of improved health at 
the population level, and citizen empowerment and self-
management.
Conclusions
Strategic purchasing is a concept introduced in Western 
Europe in the sixties [29]: since then, despite impres-
sive efforts in order to improve healthcare systems re-
sponsiveness and effectiveness and efficiency in fund-
ing allocation, there is still a long and winding road to-
wards the full implementation of strategic purchasing. 
On the one hand, health policy- and decision-makers 
need to pay attention to the different components of 
health and healthcare services delivery, in terms of pol-
icies and strategies. On the other hand, further schol-
arly research in the field is urgently needed to collect 
and provide stronger evidence of the impact and effects 
of strategic purchasing. 
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